Project Details
Description
PROJECT NARRATIVE
About 75-100 million Americans are estimated to have fatty liver disease, which can lead to nonalcoholic
steatohepatitis (NASH) and liver fibrosis. Detection of liver steatosis is important for management of NASH,
diabetes, and cardiovascular disease. In this study, we will develop and test a new ultrasound technology for
safe, cost-effective, accurate, and frequent evaluation of liver steatosis.
| Status | Finished |
|---|---|
| Effective start/end date | 9/16/20 → 6/30/22 |
Funding
- National Institute of Diabetes and Digestive and Kidney Diseases: $238,500.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.